Atherosclerotic Cardiovascular Diseases
Cardiovascular·MeSH: Inflammation
Prevalence
8121.9 / 100K
Incidence
682.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| tb-500 | IO Biotech, Inc. (IOBT) |
Frequently asked questions
How many drugs are in development for Atherosclerotic Cardiovascular Diseases?
BioSniper tracks 1 drug in development for Atherosclerotic Cardiovascular Diseases across 1 company.
How many clinical trials target Atherosclerotic Cardiovascular Diseases?
There are 1 clinical trial targeting Atherosclerotic Cardiovascular Diseases tracked by BioSniper.
What is the prevalence of Atherosclerotic Cardiovascular Diseases?
The estimated prevalence of Atherosclerotic Cardiovascular Diseases is approximately 8121.9 per 100,000 population.
Deep-dive into Atherosclerotic Cardiovascular Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis